About Me >> Current Position

Urology Mark Feneley has been a Consultant Urologist since 2000. He was appointed to his present position a Senior Lecturer in Urological Oncological Surgery at the Institute of Urology, University College London and Honorary Consultant Urologist at University College London Hospitals (UCLH) in 2004. This followed from a definitive Consultant Urological Oncological Surgeon position at the Middlesex Hospital and UCLH NHS Trust from January 2003, and prior to that Consultant Urologist with specialist interest in urological oncology at Nottingham City Hospital from 2000.

Mark is Clinical Lead for Bladder Cancer in the North Thames Cancer Network. Clinical practice includes diagnosis and treatment of urological cancers, and pelvic surgery. A recent Preceptorship at The Urological Institute, Mansoura, Egypt, awarded by the British Urological Foundation, gave me valuable additional experience of bladder cancer and its treatment. Current areas of interest include photodynamic diagnosis of bladder cancer, and electromotive drug administration for its treatment. This follows the strategy to develop effective, minimally invasive treatments in urological healthcare.

Surgical Experience and Training

Mark has particular training and expertise in major pelvic urological surgery, including nerve-sparing radical prostatectomy and radical cystectomy. Special interests include early detection of urological malignancy, investigation and treatment of early stage prostate cancer, action of testosterone in the prostate, bladder cancer, and kidney cancer. He also runs a general urological diagnostic and surgical practice for investigation, diagnosis and treatment of most urological conditions.
In 1998, he worked in the USA for two years, at the James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, Maryland. This was a Clinical Post-Doctoral Fellowship in Urological Oncology giving particular additional training and experience in advanced techniques in prostatic and pelvic surgery in a world-leading centre.

Mark qualified as a doctor at Cambridge University in 1987, and completed higher Urological training at St Bartholomew’s and Royal London Hospitals, London in 1998.

Research

As Lead Investigator in molecular biology at Prostate Cancer Research Centre, London Research interests broadly include diagnostic and prognostic molecular markers in early stage malignancy, with a large number of peer reviewed papers and book chapters in these fields. Previous postgraduate research focussed on screening and early diagnosis of prostate cancer, for which he received an MD at Cambridge University and Hunterian Professorship at the Royal College of Surgeons of England in 1997. He has also been involved with clinical and pharmaceutical trials throughout his urological training and as a consultant. He has published a large number of papers and book chapters in various fields of urology.

Teaching

As Teacher and Examiner at the Royal Free and University College Medical School, responsibilities include:-

MD Supervisor; Teacher - Institute of Urology MSc Course; Teacher - Institute of Urology GP Diploma Course; Teacher - Registrar Training Scheme; Teacher - Undergraduate Lecture Course; Teacher - Undergraduate and ward based teaching; Teacher - University College London; Organiser - Undergraduate Teaching in Urology; Examiner for MD Degree, University of London; Examiner for Undergraduate Medical Examinations and OSCI, UCL; Examiner for Diploma Course, Institute of Urology, UCL; Examiner for MSc Course, Institute of Urology, UCL; Faculty of Royal College of Surgeons Anatomy Course; Faculty of Oxford Anatomy Course.

Professional Memberships

Member of British Association of Urological Surgeons (Full, from 2000)
Member of Oncology Section, British Association of Urological Surgeons
Member of the American Association of Urological Surgeons (Corresponding, from 2001)
Member of European Association of Urology (from 2005)
Fellow of the Royal Society of Medicine
Member, Société Internationale d’Urologie (from 2006)
Medical Advisor to Prostate Research Campaign UK (from 2005)
Member of Section of Urology, Royal Society of Medicine (Council memeber 1996-98)
Member of The Society for Study of Androgen Deficiency
(Chairman - 2005; Vice-Chairman 2003 - 2005, Cttee - 2002)
Member of the British Prostate Group
Member of the British Medical Association
Member of the Bristol Urological Institute
Member of the Cambridge Medical Society

Current Medical Committee Representation

NCRI Clinical Trials Group – Bladder Cancer (from 2006)
North London Cancer Network, Member (from 2003)

Editorial Positions

Editorial Board, Clinical Oncology (from 2006)
Editorial Board, Prostate Cancer and Prostatic Disease (from 2000)